Menu
 

Search abstracts


Cost considerations of the new fixed combination for glaucoma medical therapy

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: CHEN, Hsien-Li (Chang Gung Memorial Hospital, Taipei, China Taiwan)
  • Co-author(s): Deng, Shin-Tarng (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
    Hsieh, Ming-Chieh (Chang Gung Memorial Hospital, TAOYUN, China Taiwan)
    Mau, Jan-Yen* (Chang Gung Memorial Hospital, TAIPEI, China Taiwan)
  • Abstract:

    Aims: To determine the daily cost of the CosoptÂ[RSYMBOL] (Dorzolamide/Timolol), CombiganÂ[RSYMBOL] (brimonidine tartrate/timolol), and XalacomÂ[RSYMBOL] (latanoprost /timolol) for medical therapy of glaucoma.

    Methods: The studied drugs were: CosoptÂ[RSYMBOL] (5.0 ml/ bottle) and CombiganÂ[RSYMBOL] (5.0 ml/ bottle), and XalacomÂ[RSYMBOL]..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses